NO802714L - Optisk aktive cefalosporin-analoge karbacefemforbindelser og salter derav, samt fremgangsmaate til fremstilling derav - Google Patents

Optisk aktive cefalosporin-analoge karbacefemforbindelser og salter derav, samt fremgangsmaate til fremstilling derav

Info

Publication number
NO802714L
NO802714L NO802714A NO802714A NO802714L NO 802714 L NO802714 L NO 802714L NO 802714 A NO802714 A NO 802714A NO 802714 A NO802714 A NO 802714A NO 802714 L NO802714 L NO 802714L
Authority
NO
Norway
Prior art keywords
solution
compound
compounds
enzyme
hydroxy
Prior art date
Application number
NO802714A
Other languages
English (en)
Norwegian (no)
Inventor
Fumio Suzuki
Tadashi Hirata
Takehiro Ogasa
Shigeru Kobayashi
Kiyoshi Sato
Akira Sato
Yukio Hashimoto
Seigo Takasawa
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13698679A external-priority patent/JPS5661377A/ja
Priority claimed from JP5561880A external-priority patent/JPS56152478A/ja
Priority claimed from JP10242280A external-priority patent/JPS5729291A/ja
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO802714L publication Critical patent/NO802714L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/02Preparation
    • C07D463/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
NO802714A 1979-10-25 1980-09-12 Optisk aktive cefalosporin-analoge karbacefemforbindelser og salter derav, samt fremgangsmaate til fremstilling derav NO802714L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13698679A JPS5661377A (en) 1979-10-25 1979-10-25 Optically active cephaloasporin analog
JP5561880A JPS56152478A (en) 1980-04-26 1980-04-26 Optically active cephalosporin analog
JP10242280A JPS5729291A (en) 1980-07-28 1980-07-28 Preparation of optically active cephalosporin analoge

Publications (1)

Publication Number Publication Date
NO802714L true NO802714L (no) 1981-04-27

Family

ID=27295649

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802714A NO802714L (no) 1979-10-25 1980-09-12 Optisk aktive cefalosporin-analoge karbacefemforbindelser og salter derav, samt fremgangsmaate til fremstilling derav

Country Status (7)

Country Link
EP (1) EP0027882B1 (fr)
AU (1) AU6235580A (fr)
CA (1) CA1160584A (fr)
DE (1) DE3069901D1 (fr)
DK (1) DK389180A (fr)
ES (1) ES8200142A1 (fr)
NO (1) NO802714L (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0082501A1 (fr) * 1981-12-18 1983-06-29 Kyowa Hakko Kogyo Co., Ltd Composé du type bêta-lactame et composition pharmaceutique le contenant
DE3803169A1 (de) 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
US5099015A (en) * 1991-01-10 1992-03-24 Eli Lilly And Company Trifluoromethyl 1-carba(1-dethia)cephems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7902598L (sv) * 1978-03-25 1979-10-04 Kyowa Hakko Kogyo Kk Cephalosporinanaloger

Also Published As

Publication number Publication date
EP0027882A1 (fr) 1981-05-06
CA1160584A (fr) 1984-01-17
ES495036A0 (es) 1981-10-16
DE3069901D1 (en) 1985-02-14
AU6235580A (en) 1982-07-29
DK389180A (da) 1981-04-26
ES8200142A1 (es) 1981-10-16
EP0027882B1 (fr) 1985-01-02

Similar Documents

Publication Publication Date Title
US5085992A (en) Microbial transformation process for antihypertensive products
Lebrihi et al. Phosphate repression of cephamycin and clavulanic acid production by Streptomyces clavuligerus
US3436310A (en) Hydrolysis of the acetoxymethyl group at the 3-position of the cephalosporin nucleus
EP0014476B1 (fr) Analogues acylés optiquement actifs de céphalosporines, procédés pour leur préparation et compositions pharmaceutiques les contenant
US3945888A (en) Method for the production of cephalosporins
US5066586A (en) Process for preparation of novel angiotensin II antagonists
US4335211A (en) Process for producing optically active cephalosporin analogs
DK141099B (da) Fremgangsmåde til rensning af clavulansyre eller et salt deraf med en base.
US5132216A (en) Microbial transformation process for antihypertensive products
NO802714L (no) Optisk aktive cefalosporin-analoge karbacefemforbindelser og salter derav, samt fremgangsmaate til fremstilling derav
EP0014475B1 (fr) Analogues de céphalosporine optiquement actifs, procédé pour leur préparation et leur utilisation dans la preparation des compositions pharmaceutiques
EP0025602B1 (fr) Analogues acylés de céphalosporine, procédé pour leur préparation et compositions pharmaceutiques les contenant
AU684122B2 (en) Enzymatic acylation of 3-hydroxymethly cephalosporins
US4302541A (en) Process of producing optically active cephalosporin analogs by enzyme selective deacylation
US4316958A (en) Process for producing optically active cephalosporin analogs
US4908443A (en) 7-Beta-substituted 3-lower alkanoylacetoxy-methyl-7-alpha-methoxy-3-cephem-4-carboxylic acid
US4332896A (en) Process for producing cephalosporin analogs
US4847200A (en) Biosynthesis of unnatural cephalosporins
US5045458A (en) Antibiotics PB-6042S
KR100471703B1 (ko) 알칼리게네스속미생물을사용하여헤테로방향족카르복실산을제조하는미생물학적방법
US4663450A (en) Optically active cephalosporin analogs
SU1034607A1 (ru) Способ получени оптически активных производных цис-7-амино-1-азабицикло-(4,2,0)-окт-2-ен-8-он-2-карбоновой кислоты
KR830002207B1 (ko) 7α-메톡시세팔로스포린 유도체의 제조방법
JPH0240669B2 (fr)
JPS6350356B2 (fr)